ROMPUN SOLUTION

Država: Kanada

Jezik: engleski

Izvor: Health Canada

Kupi sada

Preuzimanje Uputa o lijeku (PIL)
21-01-2021

Aktivni sastojci:

XYLAZINE (XYLAZINE HYDROCHLORIDE)

Dostupno od:

ELANCO CANADA LIMITED

Doziranje:

20MG

Farmaceutski oblik:

SOLUTION

Sastav:

XYLAZINE (XYLAZINE HYDROCHLORIDE) 20MG

Administracija rute:

INTRAMUSCULAR

Jedinice u paketu:

15G/50G

Tip recepta:

Prescription

Terapijska grupa:

CATTLE; CATS; DOGS

Proizvod sažetak:

Active ingredient group (AIG) number: 0131307002

Status autorizacije:

APPROVED

Datum autorizacije:

2021-01-21

Uputa o lijeku

                                Pr
Rompun
TM
20 mg/mL Bottle
29Oct2020
PR
ROMPUN
TM
20 MG/ML
1
BOTTLE
2
LEFT PANEL
3
DIN 02169592
4
Pr
Rompun
TM
5
(xylazine sterile injection / injection stérile de xylazine)
6
Veterinary use only /Usage vétérinaire seulement
7
8
WARNINGS: Meat – 3 days, Milk – 48 hours.
9
CONSULT PACKAGE INSERT FOR COMPLETE PRODUCT INFORMATION.
10
11
MISES EN GARDE: Viande – 3 jours, Lait – 48 heures.
12
CONSULTER LE FEUILLET D’EMBALLAGE POUR TOUTES LES INFORMATIONS
13
SUR LE PRODUIT.
14
20 mL
15

16
17
CENTER PANEL
18
ACTIVE INGREDIENTS/ INGRÉDIENTS ACTIFS:
19
Each mL contains / Chaque mL contient :
20
Xylazine: 20 mg (as xylazine hydrochloride/ sous forme de chlorhydrate
de xylazine)
21
For IV, IM or SQ injection in dogs and cats; for IM injection in
cattle.
22
Pour injection IV, IM ou SQ chez les chiens et les chats; pour
injection IM chez les
23
bovins
24
25
Elanco Canada Limited
26
150 Research Lane, Suite 120
27
Guelph, Ontario N1G 4T2
28
29
RIGHT PANEL
30
Lot:
31
Exp.:
32
Pr
Rompun
TM
20 mg/mL Package Insert
29Oct2020
PR
ROMPUN
TM
20 MG/ML
1
PACKAGE INSERT
2
3
VETERINARY USE ONLY
4
PR
ROMPUN
TM
5
(XYLAZINE STERILE INJECTION)
6
20 mg/mL
7
SEDATIVE AND ANALGESIC
8
FOR USE IN DOGS, CATS AND CATTLE
9
10
DESCRIPTION:
11
Rompun (xylazine) is supplied in 20 mL multiple-dose vials as a
sterile solution.
12
Each mL contains 20 mg Rompun (xylazine base equivalent), 0.9
methylparaben, 0.1
13
mg propylparaben, sterile water; citric acid and sodium citrate for pH
adjustment to 5.5 ±
14
0.3.
15
16
ACTIVE INGREDIENTS:
17
xylazine 2(2,6-Dimethylphenylamino)-4H-5,6-dihydro-1,3 thiazine
hydrochloride
18
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . 2.3%
19
(equivalent to 2% base)
20
Inert Ingredients: . . . . . . . . . . . . . . . . . . . . . …. . .
. . . . . . . . . . . . . . . . . . . . . . . . . 97.7%
21
Total: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . .
                                
                                Pročitajte cijeli dokument
                                
                            

Dokumenti na drugim jezicima

Uputa o lijeku Uputa o lijeku francuski 21-01-2021

Upozorenja za pretraživanje vezana za ovaj proizvod

Pogledajte povijest dokumenata